Evidence map›Paper›PMID 23636430›Full record

ArticleInternational urology and nephrology2013

Risk factors for cognitive dysfunction in CKD and hypertensive subjects.

Rigas G Kalaitzidis, Despina Karasavvidou, Athina Tatsioni, Olga Balafa, Kosmas Pappas, Giorgos Spanos, Sigkliti-Henrietta Pelidou, Kostas C Siamopoulos

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Dialysis in the Elderly: A Practical Guide for the Clinician.International journal of nephrology · 2025
    Review
  6. The Role of Hypertension in Cognitive Dysfunction.Journal of clinical medicine · 2024
    Review
  7. A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodialysis in Southern Spain.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  8. Secondary Hyperparathyroidism and Cognitive Decline.Current transplantation reports · 2023
    Article
  9. Secondary hyperparathyroidism (CKD-MBD) treatment and the risk of dementia.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Arterial damage and cognitive impairment in patients with chronic kidney disease.Journal of clinical hypertension (Greenwich, Conn.) · 2018
    Article
  15. Arterial damage and cognitive decline in chronic kidney disease patients.Journal of clinical hypertension (Greenwich, Conn.) · 2018
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rigas G KalaitzidisDepartment of Nephrology, University Hospital of Ioannina, Ioannina, Greece.
Despina Karasavvidou
Athina Tatsioni
Olga Balafa
Kosmas Pappas
Giorgos Spanos
Sigkliti-Henrietta Pelidou
Kostas C Siamopoulos
University Hospital of Ioannina · GRUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCognitive dysfunction (CO/DY) in chronic kidney disease (CKD) patients has long been recognized. Hypertension is also associated with CO/DY. The study describes associated factors with CO/DY in CKD patients compared to hypertensive subjects.

methodsNinety-six hypertensive subjects without CKD, 19 patients with CKD stages I-II, 33 with CKD III, 42 with CKD stage IV, 33 on hemodialysis (HD) and 33 on peritoneal dialysis (PD) were included in our study. Cognitive impairment measured by MMSE, clock-drawing test and IADL was considered as primary outcome.

resultsIn all groups tested, age was significantly associated with CO/DY by almost all cognitive function tests. Among CKD patients, CKD stage and DM were significantly associated with CO/DY by all three cognitive function tests. PTH levels were also associated with CO/DY by MMSE and clock-drawing tests. In hypertensives, pulse pressure (PP) was associated with CO/DY by clock-drawing and IADL tests, while those receiving CCBs as monotherapy were less likely to have CO/DY by IADL test. For dialysis patients, DM was significantly related to CO/DY by MMSE and clock-drawing tests. In the same group of patients Hb <11 g/dl was significantly correlated with CO/DY by MMSE, dialysis modality and Kt/V >1.2 by IADL test. PD patients were less likely to present with CO/DY by clock-drawing test.

conclusionsIn every CKD stage, the risk of CO/DY increased significantly. Low Hb levels (Hb <11 g/dl) and increased serum PTH levels were associated with CO/DY while DM plays also a significant role in cognitive function deterioration. Among hypertensive subjects, those with PP ≤60 mmHg or receiving CCBs showed a better executive function.

Indexed as

AdultAgedAge FactorsBlood PressureCalcium Channel BlockersCognition DisordersDiabetes MellitusExecutive FunctionFemaleHemoglobinsHumansHypertensionMaleMiddle AgedNeuropsychological TestsParathyroid HormoneCalcium Channel BlockersHemoglobinsParathyroid Hormone

Identifiers

PMID23636430
OpenAlexW2059584398

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.